arrowPath 2checkclipboardfacebookShapeShapearrowglue icongoogle-plusinstagramlinkedinplayplayrssicon searcharrowtwitteryoutube 2
Menu

Koen Kas

Prof. Dr. Koen Kas is a health care futurist, entrepreneur, professor of molecular oncology, author, and international keynote speaker.

Koen is driven by the aim to make healthcare delightful, personalized & preventive. He published his vision in two books. 'Sick no more' describes how we will transition from reactive sickcare to pro-active healthcare. 'Your guide to Delight' is a roadmap towards Creating health, dealing with change, and introducing our personal Digital Twin. In that second book, he takes DesignThinking to its next level, introducing Delight Thinking.
He is founding CEO of HealthSkouts & Partner at HealthStartup.eu. His keynotes & ideation workshops on the Future of healthcare or the Digital & DNA revolution truly inspire pharma, tech, insurance, hospitals to take action, to develop digital health strategies (beyond the pill), and to fully exploit existing resources & capabilities. He is an expert combining Real World data with design & business model innovations into novel experiences redefining Health.
This way, he develops projects for global companies (Merck, UCB, Pfizer, Nutricia /Danone, Mitsubishi, McKesson, ABInbev) always dealing with personalized, predictive or preventive health and wellness.


Koen is Prof. Oncology at Ghent University, Belgium, and chairs the scientific committee of the European Cancer Prevention Organisation.
He is an ambassador for Health House (a healthcare technology experience zone) and Geens.com (a privacy by design platform); serves on the Advisory Board of 7 pioneering healthcare companies and a digital health investor. He is jury of the Prix Galien. He is Editor of the mHealth Journal and the European Journal of Cancer Prevention.


Koen was CSO Oncology at Thrombogenics where he spun out Oncurious, testing a novel drug for pediatric brain cancer. Before he was founder & CSO of Pronota, building a protein biomarker discovery platform and pipeline of 4 diagnostic programs. He was prior to that Director Drug discovery @Galapagos. Previously he set up & directed the Cancer drug discovery program @Tibotec (now J&J). He started his career elucidating the molecular basis of 2 types of cancers.